Prevention of hepatitis B virus infection by vaccination: Progress and problems

Hepatology Research

Volumn 37, Issue 9, 2007, Pages 673-675

  Michitaka, Kojiro ^a   Akbar, Fazle ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; CHRONIC FATIGUE SYNDROME; DEMYELINATING DISEASE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; DRUG SYNTHESIS; EDITORIAL; GENETIC VARIABILITY; HEPATITIS B; HUMAN; INFECTION CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKEMIA; MULTIPLE SCLEROSIS; MYALGIA; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROCONVERSION; SEXUAL TRANSMISSION; SOCIOECONOMICS; VACCINATION; VERTICAL TRANSMISSION; VIRUS GENE; VIRUS IMMUNITY; VIRUS MUTANT; VIRUS TRANSMISSION;

EID: 34447328984     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00145.x     Document Type: Editorial

References (29)

1. Duclos P. Safety of immunization and adverse events following vaccination against hepatitis B. J Hepatol 2003; 39: S83-S88.
2. Lavanchy D. Hepatitis B epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
3. Shouval D. Hepatitis B virus vaccines. J Hepatol 2003; 39: S70-S76.
4. Rendi-Wanger P, Shouval D, Genton B et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non-and low responders to conventional vaccine. Vaccine 2006; 24: 2781-9.
5. World Health Organization (WHO). [Cited Feb 2002.]Available from URL: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/ index3.html#phases.
6. Rottinghaus ST, Poland GA, Jacobson RM, Barr LJ, Roy MJ. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 2003; 21: 4604-8.
7. Akbar SM, Furukawa S, Yoshida O, Hiasa Y, Horiike N, Onji M. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells. J Hepatol (in press).
8. Furukawa S, Akbar SMF, Hasebe A, Horiike N, Onji M. Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressd murine hepatitis B virus carier: Evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo. Imunobiology 2004; 209: 551-7.
9. Schattner. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23: 3876-86.
10. Resti M, Azzari C, Mannelli F, Rossi ME, Lionetti P, Vierucci A. Ten-year follow-up study of neonatal hepatitis B immunization: Are booster injections indicated? Vaccine 1997; 15: 1338-40.
11. Fitzsimons D, Francois G, Hall A et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23: 4158-66.
12. Zanetti AR, Mariano A, Romano L et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: An Italian multicentre study. Lancet 2005; 366: 1379-84.
13. Hsu HY, Chang MH, Liaw YH et al. Changes of hepatitis B surface antigen variants in carrier before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312-17.
14. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 2000; 355: 1382-3.
15. Ogata N, Cote PJ, Zanetti AR et al. Licenced recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 1999; 30: 779-86.
16. Tacke F, Amini-Bavil-Olyaee S, Heim A, Luedde T, Manns MP, Trautwein C. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol 2007; 38: 353-7.
17. Mathet VL, Cuestas ML, Ruiz V et.al. Detection of hepatitis B virus (HBV) genotype E carried-even in the presence of high titers of anti-HBs antibodies - by an Argentinean patient of African descent who had received vaccination against HBV. J Clin Microbiol 2006; 44: 3435-9.
18. Aono J, Yotsuyanagi H, Miyoshi H et al. Amino acid substitution in S region of hepatitis B virus in the sera from patients with acute hepatitis. Hepatol Res 2007; 37: 731-9.
19. Ozasa A, Tanaka Y, Orito E et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44: 326-34.
20. Matsuura K, Michitaka K, Yamauchi K et al. Characteristics of geographic distributions and route of infection for hepatitis B virus genotype D in Ehime area in western Japan. Hepatol Res 2007; 37: 255-62.
21. Huang KH, Lin SR. Nationwide vaccination: A success story in Taiwan. Vaccine 2000; 18: S35-S38.
22. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA. The first five years of universal hepatitis B vaccination in South Africa: Evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001; 19: 3919-26.
23. Bonanni P, Pesavento G, Bechini A et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10years of experience in Italy. Vaccine 2003; 21: 685-91.
24. Eto T, Shiraki K. National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan. Acta Paediatr Jpn 1989; 31: 681-4.
25. Koyama T, Matsuda I, Sato S, Yoshizawa H. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxix in Iwate, Japan (1981-92) and epidemiological evidence for its efficacy. Hepatol Res 2003; 26: 287-92.
26. Miyakawa Y, Yoshizawa H. Immunoprophylaxis of perinatal infection with hepatitis B virus on the national scale. Hepatol Res 2006; 36: 255-8.
27. Inui A, Komatsu H, Sogo T, Nagai T, Abe K, Fujisawa T. Hepatitis B virus genotypes in children and adolescents in Japan. Before and after immunization for the prevention of mother to infant transmission of hepatitis B virus. J Med Virol 2007; 79: 670-5.
28. Arima S, Michitaka K, Horiike N et.al. Change of acute hepatitis B transmission routes in Japan. J Gastroenterol 2003; 38: 772-5.
29. Sugauchi F, Orito E, Ohno T et.al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res 2006; 36: 107-14.